請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37919完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 江俊斌 | |
| dc.contributor.author | Yen-Hung Lin | en |
| dc.contributor.author | 林彥宏 | zh_TW |
| dc.date.accessioned | 2021-06-13T15:51:09Z | - |
| dc.date.available | 2008-08-13 | |
| dc.date.copyright | 2008-08-13 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-06-25 | |
| dc.identifier.citation | Ampil FL, Hardin JC, Peskind SP, Stucker FJ. Perineural invasion in skin cancer of the head and neck: a review of nine cases. J Oral Maxillofac Surg;53:34-8, 1995.
Anneroth G, Hansen LS. A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res;92:448-68, 1984. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res;95:229-49, 1987. Allan K, Jordan RC, Ang LC, Taylor M, Young B Overexpression of cyclin A and cyclin B1 proteins in astrocytomas. Arch Pathol Lab Med 124:216–220, 2000. Arion D, Meijer L, Brizuela L, Beach D cdc2 is a component of the M phase-specific histone H1 kinase: evidence for identity with MPF. Cell 55:371–378, 1988. Bankfalvi A, Piffko J. Prognostic and predictive factors in oral cancer: the role of the invasive tumor front. J Oral Pathol Med;29:291-8, 2000. Brizuela L, Draetta G, Beach D p13suc1 acts in the fission yeast cell division cycle as a component of the p34cdc2 protein kinase. EMBO J 6:3507–3514, 1987. Batsakis JG. Surgical excision margins: a pathologist’s perspective. Adv Anat Pathol;6:140-8, 1999. Bettendorf O, Piffko J, Bankfalvi A. Prognostic and predictive factors in oral squamous cell cancer: important tools for planning individual therapy, Oral Oncol;40:110-9, 2004. Broders AC. Squamous cell epithelioma of the lip. J Am Med Assoc;74:656-64, 1920 . Brown B, Barnes L, Mazariegos J, Taylor F, Johnson J, Wagner RL. Prognostic factors in mobile tongue and floor of mouth carcinoma. Cancer;64:1195-202, 1989. Bryne M, Koppang HS, Lilleng R, Kjaerheim A. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol;166:375-81, 1992. Byers RM, O’Brien J, Waxler J. The therapeutic and prognostic implications of nerve invasion in cancer of the lower lip. Int J Radiat Oncol Biol Phys;4:215-7, 1978. Cancer registry annual report in Taiwan area, 2007. Department of Health, The Executive Yuan, Taiwan, 2008. Carter RL, Bliss JM, Soo KC, O’Brien CJ. Radical neck dissections for squamous carcinomas: pathological findings and their clinical implications with particular reference to transcapsular spread. Int J Radiat Oncol Biol Phys;13:825-32, 1987. Chambers AF, Tuck AB. Ras-responsive genes and tumor metastasis. Crit Rev Oncogenes;4:95-114, 1993. Chang JYF, Lin MC, Chiang CP. High-risk human papillomaviruses may have an important role in non-oral habits-associated oral squamous cell carcinomas in Taiwan. Am J Clin Pathol;120:909-16, 2003. Chattopadhyay A. Epidemiologic study of oral cancer in Eastern India. Indian J Dermatol;4:59-65, 1989. Chen HM, Kuo MYP, Lin KH, Lin CY, Chiang CP. Expression of cyclin A is related to progression of oral squamous cell carcinoma in Taiwan. Oral Oncol;39:476-82, 2003. Chen YK, Huang HC, Lin LM, Lin CC. Primary oral squamous cell carcinoma: an analysis of 703 cases in southern Taiwan. Oral Oncol;35:173-9, 1999. Chen YS, Wang JT, Chang YF, Liu BY, Wang YP, Sun A, Chiang CP. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan. J Oral Pathol Med;33:209-17, 2004. Chiang CP, Huang JS, Wang JT, Liu BY, Kuo YS, Hahn LJ, Kuo MYP. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med;28:72-6, 1999. Chiang CP, Lang MJ, Liu BY, Wang JT, Leu JS, Hahn LJ, Kuo MYP. Expression of p53 protein in oral submucous fibrosis, oral epithelial hyperkeratosis and epithelial dysplasia. J Formos Med Assoc;99:229-34, 2000. Control of Oral Cancer in Developing Countries – W.H.O. meeting report. World Health Bulletin;62:817-30, 1984. Cress WD, Seto E. Histone deacetylases, transcriptional control, and cancer. J Cell Physiol;184:1-16, 2000. Crissman JD, Gluckman J, Whiteley J, Quanelle O. Squamous cell carcinoma of the floor of mouth. Head Neck Surg;3:2-7, 1980. Crissman JD, Liu WY, Gluckman JL, Cummings G. Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx. Cancer;54:2995-3001, 1984. Curtis HS, Couse JF, Korach KS. Estrogen receptor transcription and transactivation: estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Res;2:345-52, 2000. Draetta G, Brizuela L, Potashkin J, Beach D Identification of p34 and p13, human homologs of the cell cycle regulators of fission yeast encoded by cdc2+ and suc1+. Cell 50:319–325, 1987. Dukes CE, Bussey HJR The spread of rectal cancer and its effect on prognosis. Br J Cancer 12:309–320, 1958. Draetta G, Beach D. Activation of cdc2 protein kinase during mitosis in human cells: cell cycle dependent phosphorylation and submit rearrangement. Cell;54:17—26, 1988 . Dalton S. Cell cycle regulation of the human cdc2 gene. EMBOJ;11:1797—1804, 1992. Fagan JJ, Collins B, Barnes L, D’Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg;124:637-40, 1998. Felsenfeld G, Groudine M. Controlling the double helix. Nature;421:448-53, 2003. Fisher HR. Grading of biopsies of laryngeal carcinomas by multiple criteria. Can J Otolaryngol;4:881-4, 1975. Frierson HF Jr, Cooper PH. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol;17:346-54, 1986. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell;113:207-19, 2003. Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT. Presentation, treatment, and outcome of oral cavity cancer: a national cancer data base report. Head Neck;24:165-80, 2002. Florenes VA, Malandsmo GM, Faye R, Nesland JM, Holm R Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome. J Pathol 195:530–536, 2001. Furihata M, Ishikawa T, Inoue A, Yoshikawa C, Sonobe H, Ohtsuki Y, Araki K, Ogoshi S Determination of the prognostic significance of unscheduled cyclin A over-expression in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2:1781–1785, 1996. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293–302, 1991. Gillies EM, Luna MA. Histologic evaluation of neck dissection specimens. Otolaryngol Clin North Am;31:759-71, 1998. Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg;148:542-7, 1984 . Grunstein M. Histone acetylation in chromatin structure and transcription. Nature;389:349-52, 1997. Harada H, Omura K, Nakajima Y, Hasegawa S, Mogi S. Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma. J Exp Clin Cancer Res; 25:351-6, 2006. Hassig CA, Schreiber SL. Nuclear histone acetylases and deacetylases and transcriptional regulation. HATs off to HDACs. Curr Opin Chem Biol;1:300-8, 1997. Hermanek P, Sobin LS. UICC TNM Classification of malignant tumors. Berlin: Springer-Verlag; 1987. Hiratsuka H, Imamura M, Ishii Y, Kohama G-I, Kikuchi K. Immunohistologic detection of lymphocyte subpopulations infiltrating in human oral cancer with special reference to its clinical significance. Cancer;53:2456-66, 1984. Hofer MD, Kuefer R, Varambally S, Li H, Ma J, Shapiro GI, Gschwend JE, Hautmann RE, Sanda MG, Giehl K, Menke A, Chinnaiyan AM, Rubin MA. The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res;64:825-9, 2004. Hofer MD, Menke A, Genze F, Gierschik P, Giehl K. Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. Br J Cancer;90:455-62, 2004. Huang JS, Ho TJ, Chiang CP, Kok SH, Kuo YS, Kuo MYP. MDM2 expression in areca quid chewing-associated oral squamous cell carcinoma in Taiwan. J Oral Pathol Med;30:53-8, 2001. Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology; 59:68-74, 2000. IARC. Betel-quid and areca-nut chewing. Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Lyon, France: International Agency for Research on Cancer;pp.141-202, 1985 . Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma. Oncology 59:68–74, 2000. Japanese Research Society for Cancer of the Colon and Rectum General rules for clinical and pathologic studies on cancer of the colon, rectum and anus. Jpn J Surg 13: 557–573, 1983. Jessus C, Beach D. Oscillation of MPF is accompanied by periodic association between cdc25 and cdc2-cyclin B. Cell 68:323–332, 1992. Jakobsson PA, Eneroth CM, Killander D, Moberger G, Martensson B. Histologic classification and grading of malignancy in carcinoma of the larynx (a pilot study). Acta Radiol Ther Phys Biol;12:1-8, 1973 . Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, CA Cancer J Clin;55:10-30, 2005. Jeng JH, Kuo ML, Hahn LJ, Kuo MYP. Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J Dent Res;73:1043-9, 1994. Kalnins IK, Leonard AG, Sako K, Razack MS, Shedd DP. Correlation between prognosis and degree of lymph node involvement in carcinoma of oral cavity. Am J Surg;134:450-4, 1977. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formos Med Assoc, 75: 497-505, 1976. Ko YC, Chiang TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med;21:261-4, 1992. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med;24:450-3, 1995 . Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res;55:1856-62, 1995. Kuo MYP, Jeng JH, Chiang CP, Hahn LJ. Mutations of Ki-ras oncogenes codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. J Oral Pathol Med;23:70-4, 1994. Kuo MYP, Chang HH, Hahn LJ, Wang JT, Chiang CP. Elevated ras p21 expression in oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med;24:255-60, 1995. Kuo MYP, Cheng SJ, Chen HM, Kok SH, Hahn LJ, Chiang CP. Expression of CD44s, CD44v5, CD44v6 and CD44v7-8 in betel quid chewing-associated oral premalignant lesions and squamous cell carcinomas in Taiwan. J Oral Pathol Med;27:428-33, 1998. Kuo MYP, Lin CY, Hahn LJ, Chiang CP. Expression of cyclin D1 is correlated with poor prognosis in patients with areca quid chewing-related oral squamous cell carcinomas in Taiwan. J Oral Pathol Med;28:165-9, 1999. Kuo MYP, Huang JS, Hsu HC, Chiang CP, Kok SH, Kuo YS, Hong CY. Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med;28:221-5, 1999. Kuo MYP, Huang JS, Kok SH, Kuo YS, Chiang CP. Prognostic role of p21WAF1 expression in areca quid chewing and smoking-associated oral squamous cell carcinoma in Taiwan. J Oral Pathol Med;31:16-22, 2002. Kuo MYP, Hsu HY, Kok SH, Kuo RC, Yang H, Hahn LJ, Chiang CP. Prognostic role of p27Kip1 expression in oral squamous cell carcinoma in Taiwan. Oral Oncol;38:172-8, 2002. Kwan HW. A statistical study on oral carcinomas in Taiwan with emphasis on the relationship with betel nut chewing: a preliminary report. J Formos Med Assoc;75:497-505, 1976 . Kallakury BV, Sheehan CE, Rhee SJ, Fisher HA, Kaufman RP Jr, Rifkin MD, Ross JS The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2. Cancer 85:1569–1576, 1999. Kammerer U, Kapp M, Gassel AM, Richter T, Tank C, Dietl J, Ruck P A new rapid immunohistochemical staining technique using the EnVision antibody complex. J Histochem Cytochem 49:623–630, 2001. Korenaga D, Takesue F, Yasuda M, Honda M, Nozoe T, Inutsuka S The relationship between cyclin B1 overexpression and lymph node metastasis in human colorectal cancer. Surgery 131:S114–S120, 2002. Lees JA, Buchkovich KJ, Marshak DR, Anderson CW, Harlow E The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J 10:4279–4290, 1991. Lew DJ, Kornbluth S Regulatory roles of cyclin dependent kinase phosphorylation in cell cycle control. Curr Opin Cell Biol 8:795–804, 1996. Li JQ. Kubo A. Wu F. Usuki H. Fujita J. Bandoh S. Masaki T. Saoo K. Takeuchi H. Kobayashi S. Imaida K. Maeta H. Ishida T. Kuriyama S. Cyclin B1, unlike cyclin G1, increases significantly during colorectal carcinogenesis and during later metastasis to lymph nodes. Int J Oncol; 22:1101-10, 2003. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Regional lymph node involvement and its significance in the development of distance metastasis in head and neck carcinoma. Cancer;71:452-6, 1993. Lo WL, Kao SY, Chi LY, Wong YK, Chang RCS. Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg;61:751-8, 2003. Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Curr Opin Oncol, 13: 176-182, 2001. Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg;160:410-4, 1990. Lund C, Sogaard H, Elbrond O, Jorgensen K, Pedersen AP. Epidermoid carcinoma of the lip. Histologic grading in the clinical evaluation. Acta Radiol Ther Phys Biol;14:465-74, 1975. Lund C, Sogaard H, Elbrond O, Jorgensen K, Pedersen AP. Epidermoid carcinoma of the tongue. Histologic grading in the clinical evaluation. Acta Radiol Ther Phys Biol;14:513-21, 1975. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg;168:494-8, 1994. Martinez-Gimeno C, Rodriguez EM, Vila CN, Varela CL. Squamous cell carcinoma of the oral cavity: a clinicopathologic scoring system for evaluating risk of cervical lymph node metastasis. Laryngoscope;105:728-33, 1995. Mazumdar A, Wang RA, Mishra SK, Adam L, Bagher-Yarmand R, Mandal M, Vadlamudi RK, Kumar R. Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nature Cell Bio;3:30-7, 2001. McGavran MH, Bauer WC, Ogura JH. The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. Cancer;14:55-66, 1961. Moon WS, Chang K, Tarnawski AS. Overexpression of metastatic tumor antigen 1 in hepatocellular carcinoma: relationship to vascular invasion and estrogen receptor-α. Hum Pathol;35:424-9, 2004. Muir C, Weiland L. Upper aerodigestive tract cancers. Cancer;75:S147-53, 1995. Morla AO, Draetta G, Beach D, Wang JY Reversible tyrosine phosphorylation of cdc2: dephosphorylation accompanies activation during entry into mitosis. Cell 58:193–203, 1989. Murakami H, Furihata M, Ohtsuki Y, Ogoshi S Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 434:153–158, 1999. Nigg EA Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17:471–480, 1995. Nozoe T, Korenaga D, Kabashima A, Ohga T, Saeki H, Sugimachi K Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus. Clin Cancer Res 8:817–822, 2002. Neville BW, Damm DD, Allen CM, Bouquot JE. Epithelial Pathology. In: Oral Maxillofacial Pathology ;259-321, 1995 Norton SA. Betel: consumption and consequences. J Am Acad Dermatol;38:81-8, 1998. Okada Y, Mataga I, Katagiri M, Ishii K. An analysis of cervical lymph nodes metastasis in oral squamous cell carcinoma: relationship between grade of histopathological malignancy and lymph nodes metastasis. Int J Oral Maxillofac Surg;32:284-88, 2003. Osborne CK. Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat;51:227-38, 1998. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin;47:5-27, 1997. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers. Int J Cancer;54:594-606, 1993. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clinur;55:74-108, 2005. Pines J, Hunter T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature; 346:760-3, 1990. Pines J, Hunter T Isolation of a human cyclin cDNA: evidence for cyclin mRNA and protein regulation in the cell cycle and for interaction with p34cdc2. Cell 58:833–846, 1989. Pondborg JJ, Reichart PS, Smith CJ, Waal van der I. Histological typing of cancer and precancer of oral mucosa. Berlin, Heidelberg: World Health Organization/Springer-Verlag; 1997. Rahima B, Shingaki S, Nagata M, Saito C. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oraal Radiol Endod;97:423-31, 2004. Rasgon BM, Cruz RM, Hilsinger RL, Sawicki JE. Relation of lymph-node metastasis to histopathologic appearance in oral cavity and oropharyngeal carcinoma: a case series and literature review. Laryngoscope;99:1103-10, 1989. Richard JM, Sancho-Garnier H, Micheau C, Saravane D, Cachin Y. Prognostic factors in cervical node metastasis in upper respiratory and digestive tract carcinomas: study of 1713 cases during a 15 year period. Laryngoscope;97:97-101, 1987. Sanghvi LD. Cancer epidemiology: the Indian scene. J Cancer Res Clin Oncol 99:1-14, 1981. Sasaki H, Moritama S, Nakashima Y, Kobayashi Y, Yukiue H, Kaji M, Fukai I, Kiriyama M, Yamakawa Y, Fujii Y. Expression of the MTA1 mRNA in advanced lung cancer. Lung Cancer;35:149-54, 2002. Schliephake H. Prognostic relevance of molecular markers of oral cancer – a review. Int J Oral Maxillofac Surg;32:233-45, 2003. Schwartz JL. Biomarkers and molecular epidemiology and chemoprevention of oral carcinogenesis. Crit Rev Oral Biol Med;11:92-122, 2000 . Shingaki S, Suzuki I, Nakajima T, Kawasaki T. Evaluation of histopathologic parameters in predicting cervical lymph node metastasis of oral and oropharyngeal carcinomas. Oral Surg Oral Med Oral Pathol;66:683-8, 1988. Shingaki S, Takada M, Suzuki I, et al. Impact of clinicopathologic parameters on survival of patients with tongue carcinoma. Asian J Oral Maxillofac Surg;9:107-16, 1997 . Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, Saito C. Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg;185:278-84, 2003. Simpson A, Uitto J, Rodeck U, Mahoney MG. Differential expression and subcellular distribution of the mouse metastasis-associated proteins Mta1 and Mta3. Gene;273:29-39, 2001. Snow GB, Aanyas AA, van Slooten EA, Bartelink H, Hart AA. Prognostic factors in neck node metastasis. Clin Otolaryngol;7:185-92, 1982 . Sobin LH, Wittekind C, eds. International Union Against Cancer. TNM classification of malignant tumors. 5th ed. New York: Weiley-Liss, pp. 17-43, 1997. Song Y, Zhao C, Dong L, Fu M, Xue L, Huang Z, Tong T, Zhou Z, Chen A, Yang Z, Lu N, Zhan Q. Overexpression of cyclin B1 in human esophageal squamous cell carcinoma cells induces tumor cell invasive growth and metastasis. Carcinogenesis; 29:307-15, 2008. Sundqvist H, Liu Y, Nair J, Bartsch H, Arvidson H, Grafstrom RC. Cytotoxic and genotoxic effect of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res;49:5294-8, 1989 . Sutton DN, Brown JS, Rogers SN, Vaughan ED, Woolgar JA. The prognostic implications of the surgical margin in oral squamous cell carcinoma. Int J Oral Maxillofac Surg;32:30-4, 2003. Sabattini E, Bisgaard K, Ascani S, Poggi S, Piccioli M, Ceccarelli C, Pieri F, Fraternali-Orcioni G, Pileri SA The EnVision system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 51:506–511, 1998. Sobin LH, Wittekind C International Union Against Cancer. TNM classification of malignant tumours, 5th edn. Wiley-Liss, New York, pp 54–58Volm M, Kooma‥ gi R, Mattern J, Stammler G Cyclin A is associated with an unfavourable outcome in patients with nonsmall-cell carcinoma. Br J Cancer 75:1774–1778, 1997. Taiwan area main causes of death 2003, Department of Health, The Executive Yuan, Taiwan, R.O.C., 2004. Takeno S, Noguchi T, Kikuchi R, Uchida Y, Yokoyama S, Muller W. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma. Cancer; 94:2874-81, 2002. Thomas S, Kearsley J. Betel quid and oral cancer: a review. Eur J Cancer B Oral Oncol;29B:251-5, 1993. Thomas SJ, MacLennan R. Slaked lime and betel nut cancer in Papua New Guinea. Lancet;340:577-8, 1992. Toh Y, Pencil SD, Nicolson GL. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem;269:22958-63, 1994 . Toh Y, Pencil SD, Nicolson GL. Analysis of the complete sequence of the novel metastasis-associated candidate gene, mta1, differentially expressed in mammary adenocarcinoma and breast cancer cell lines. Gene;159:97-104, 1995. Toh Y, Oki E, Oda S, Tokunaga E. Ohno S, Maehara Y, Nicolson GL, Sugimachi K. Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis. Int J Cancer;74:459-63, 1997. Toh Y, Kuwano H, Mori M, Nicolson GL, Sugimachi K. Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer;79:1723-6, 1999 . Toh Y, Kuninaka S, Endo K, Oshiro T, Ikeda Y, Nakashima H, Baba H, Kohnoe S, Okamura T, Nicolson GJ, Sugimachi K. Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. J Exp Clin Cancer Res;19:105-11, 2000. Toh Y, Ohga T, Endo K, Adachi E, Kusumoto H, Haraguchi M, Okamura T, Nicolson GL. Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer;110:362-7, 2004. Wang C, Fu M, Mani S, Wadler S, Senderowicz AM, Pestell RG. Histone acetylation and the cell-cycle in cancer. Front Biosci;6:610-29, 2001. Warnakulasuriya S, Trivedy C, Peters TJ. Areca nut use: an independent risk factor for oral cancer. Br Med J;324:799-800, 2002 . Willen R, Nathanson A, Moberger G, Anneroth G. Squamous cell carcinoma of the gingiva. Histological classification and grading of malignancy. Acta Otolaryngol;79:146-54, 1975. Welch PJ, Wang JYJ. Coordlnated synthesis and degradation of cdc2 in the mammalian cell cycle. Proc Natl Acad Sci USA;89:3093—3097, 1992. Winters ZE, Hunt NC, Bradburn MJ, Royds JA, Turley H, Harris AL, Norbury CJ Subcellular localisation of cyclin B, Cdc2 and p21(WAF1/CIP1) in breast cancer: association with prognosis. Eur J Cancer 37:2405–2412, 2001. Williams HK. Molecular pathogenesis of oral squamous carcinoma. J Clin Pathol: Mol Pathol;53:165-72, 2000. Woolgar JA, Rogers S, West CR, Errington RD, Brown JS, Vaughan ED. Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol;35:257-65, 1999. Xue Y, Wong J, Moreno GT, Young MK, Cote J, Wang W. NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. Mol Cell;2:851-61, 1998. Yamamoto E, Miyakawa A, Kohama GI. Mode of invasion and lymph node metastasis in squamous cell carcinoma of the oral cavity. Head Neck Surg;6:938-47, 1984. Yao Ya-Li, Yang Wen-Ming. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem;278:42560-8, 2003 . Yasuda M, Takesue F, Inutsuka S, Honda M, Nozoe T, Korenaga D Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: an immunohistological study. J Cancer Res Clin Oncol 128:412–416, 2002. Yasui W, Ayhan A, Kitadai Y, Nishimura K, Yokozaki H, Ito H, Tahara E Increased expression of p34cdc2 and its kinase activity in human gastric and colonic carcinomas. Int J Cancer 53:36–41, 1993. Yuen APW, Lam KY, Wei WI, Lam KY, Ho CM, Chow TL, Yuen WF. A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma. Am J Surg;180:139-43, 2000 . Yuen APW, Lam KY, Lam LK, Ho CM, Wong A, Chow TL, Yuen WF, Wei WI. Prognostic factors of clinically stage I and II oral tongue carcinoma – a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck;24:513-20, 2002 . Zain RB, Gupta PC, Warnakulasuriya S, Shrestha P, Ikeda N, Axell T. Oral lesions associated with betel quid and tobacco chewing habits. Oral Dis;3:204-5, 1997 . Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR. The national cancer data base report on squamous cell carcinoma of the base of tongue. Head Neck;26:660-74, 2004 . | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37919 | - |
| dc.description.abstract | 背景：P34cdc2在人類不同的癌症中被發現有過度表現的現象，而且和腫瘤的大小、淋巴結的轉移、臨床的分期、或病人的預後等有統計上有意義的相關。
方法：本研究利用免疫組織化學染色的方法，探討P34cdc2於81例口腔鱗狀細胞癌（OSCC），95例口腔上皮變異（ED；29例輕度，43例中度，23例重度上皮變異），和14例正常口腔黏膜（NOM）之表現。我們計算在口腔鱗狀細胞癌、口腔上皮變異與正常口腔黏膜中的細胞質P34cdc2標記指數（labeling indices, LIs），並比較各組間的差異。我們同時利用統計方法來分析細胞質P34cdc2標記指數與口腔鱗狀細胞癌病人的臨床病理參數與存活率的相關性。 結果：細胞質P34cdc2平均標記指數，從NOM之6±7%，至輕度ED之18±10%，至中度ED之23±11%，至重度ED之40±22%，至OSCC之73±20%，有隨著惡性程度的增加而呈現統計學上有意義增高的情形（P=0.000)。統計分析的結果也顯示，細胞質P34cdc2平均標記指數在OSCCs中之較高表現和OSCCs發生在有局部淋巴結的轉移,較高的臨床分期與較高度分化之病理組織學上分類的程度，有統計學上有意義之相關。 結論：我們的結果顯示， P34cdc2的表現度可以在口腔癌的初期形成而且也扮演一個重要的角色。因此細胞質P34cdc2標記指數可預測台灣OSCC的進展。 | zh_TW |
| dc.description.abstract | Background: Overexpression of p34cdc2 has been demonstrated in a variety of human cancers and found to be significantly associated with the tumor size, lymph node metastasis, clinical stage, or prognosis of these cancers.
Methods: In this study, we examined the expression of p34cdc2 in 81 specimens of oral squamous cell carcinoma (OSCC), 95 specimens of oral epithelial dysplasia (OED; 29 mild, 43 moderate, and 23 severe OED cases), and 14 specimens of normal oral mucosa (NOM) by immunohistochemistry. The cytoplasmic p34cdc2 labeling indices (LIs) in OSCC, OED, and NOM samples were calculated and compared between groups. The correlation between the cytoplasmic p34cdc2 LI in OSCCs and clinicopathological parameters or survival of OSCC patients was analyzed statistically. Results: The mean cytoplasmic p34cdc2 LIs increased significantly from NOM (6±7%) through mild (18±10%), moderate (23±11%), and severe OED (40±22%) to OSCC samples (73±20%, P = 0.000). A significant correlation was found between the higher mean cytoplasmic p34cdc2 LIs and positive regional lymph node metastases (P = 0.013), more advanced clinical stages (P = 0.022) or higher differentiation of cancer cells (P = 0.028). Conclusion: Our results suggest that the p34cdc2 expression is an early event in oral carcinogenesis and may play an important role in oral carcinogenesis. The cytoplasmic p34cdc2 LI may be used as a biomarker to predict the progression of OSCCs in Taiwan. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T15:51:09Z (GMT). No. of bitstreams: 1 ntu-97-R95422014-1.pdf: 6357018 bytes, checksum: e9fe4963d5d094e3248cdcae7b54909e (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | 口試委員會審定書
中文摘要 7 Abstract 8 Introduction 9 Background 11 Purposes of this study 13 Literature Review 14 Part 1: Introduction of oral squamous cell carcinoma 14 (i)Epidemiology in the world 14 (ii)Epidemiology in Taiwan 14 (iii)Etiology 15 (iv)Clinical presentation 17 (v)Histologic features 19 (vi)Grading of oral squamous cell carcinoma 19 (vii) Our previous studies on oral cancers 20 Part 2: Prognostic factors of oral squamous cell carcinoma 22 (i)Clinical factors 23 (ii)Histopathologic factors 24 (iii)Molecular factors 30 Part 3: P34cdc2 31 (i)Structure of protein and gene location 31 (ii)Function of P34cdc2 33 (iii)Regulation of P34cdc2 expression 35 (iv)P34cdc2 expression in normal cells 35 (v)P34cdc2 expression in tumor cell lines 36 (vi)P34cdc2expression in cancers 36 (vii)P34cdc2 expression in OSCC 37 Materials and Methods Part 1: Patients and specimens 38 Part 2: Immunohistochemical staining for P34cdc2 39 Part 3: Statistical analysis 40 Results Part 1: The cytoplasmic p34cdc2 positive staining rates, mean LIs, and median SIs for NOM, ED, and OSCC samples 42 Part 2: Correlation between cytoplasmic P34cdc2 LIs in OSCCs and clinicopathological parameters of OSCC patients 42 Part 3: Correlation between cytoplasmic P34cdc2 LIs in OSCCs and oral habits of OSCC patients 43 Part 4: Correlation between cytoplasmic P34cdc2LIs in OSCCs and survival of OSCC patients 43 Discussion 44 Conclusions 47 References 48 Tables 64 Figures 67 | |
| dc.language.iso | en | |
| dc.subject | 口腔癌前病變 | zh_TW |
| dc.subject | P34cdc2 | zh_TW |
| dc.subject | 口腔癌 | zh_TW |
| dc.subject | oral cancer | en |
| dc.subject | oral precancer | en |
| dc.subject | p34cdc2 | en |
| dc.title | P34cdc2於口腔癌前病變及口腔鱗狀細胞癌之表現 | zh_TW |
| dc.title | Expression of P34cdc2 in oral precancers and oral squamous cell carcinomas | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 關學婉,張龍昌 | |
| dc.subject.keyword | P34cdc2,口腔癌,口腔癌前病變, | zh_TW |
| dc.subject.keyword | p34cdc2,oral cancer,oral precancer, | en |
| dc.relation.page | 72 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2008-06-26 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 臨床牙醫學研究所 | zh_TW |
| 顯示於系所單位： | 臨床牙醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf 未授權公開取用 | 6.21 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。